TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. (TLSI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
tlsi · stock forecast · 3 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$8.00
Consensus
$8.00
+149.2% upside
Low
$8.00
Median: $8 · Last Close: $3.21
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.15 | ↓ 1.77% |
1-day model range: $3.09–$3.22. Peak: $3.22 (-1.77%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -44.0% |
| 2028 | $1 | -56.4% |
| 2029 | $1 | -61.2% |
| 2030 | $1 | -63.3% |
| 2031 | — | -64.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TLSI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Lake Street | Maintains | Buy→Buy |
| 2026-03-09 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-03-28 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-01-24 | Roth MKM | Maintains | Buy→Buy |
| 2024-11-15 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-06-27 | Canaccord Genuity | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on TriSalus Life Sciences, Inc. (TLSI) stock. Of the recent 8 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover TLSI.
Analyst Recommendation Trends
TLSI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$54M
↓ 50.8% YoY
Revenue Next Year
$78M
↑ 46.1% YoY
EPS This Year
$-0.32
EPS Next Year
$-0.16
↓ 49.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast TLSI EPS of $-0.32 for the current fiscal year, based on estimates from 2 analysts. The TLSI revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TLSI stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TLSI price target is $8.00 (+149.2% upside), with an analyst consensus of Buy.
The TLSI short-term stock prediction for tomorrow is $3.15 (-1.77%). The TLSI stock price prediction for 2027 estimates an average of $2. The TLSI stock prediction for 2030 projects a range of $1–$1.
TriSalus Life Sciences, Inc. trades on NASDAQ under the ticker TLSI. The TLSI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
TLSI forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month TLSI price target is $8.00, with a high forecast of $8.00 and a low of $8.00. The median price target is shown in the chart above when available. This implies +149.2% potential upside from the current price of $3.21.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.